Product Information

PIOGLITAZONE-GLIMEPIRIDE 30-4 is a generic product labeled by Prasco Laboratories, priced at $10.9734 per EA under NDC 66993082230. Its NADAC has been published 295 times since Oct 7, 2015.

PIOGLITAZONE-GLIMEPIRIDE 30-4

pioglitazone and glimepiride
$10.9734per EA

Strength

4; 30 mg/1; mg/1

NDC

66993082230

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021925

On Market Since

8/4/2015

Pharmacological Classes

Peroxisome Proliferator Receptor alpha Agonist
Peroxisome Proliferator Receptor gamma Agonist
Peroxisome Proliferator-activated Receptor alpha Agonists
Peroxisome Proliferator-activated Receptor gamma Agonists
Sulfonylurea Compounds
Sulfonylurea
Thiazolidinedione
Thiazolidinediones

Price Statistics

The NADAC for PIOGLITAZONE-GLIMEPIRIDE 30-4 has been published 295 times since Oct 7, 2015, and over the history we have for it it has risen 15.1%. The table below summarizes its recorded NADAC range and movement.

Current price$10.9734 per EA
All-time high$13.3590 (May 11, 2016)
All-time low$7.7896 (Nov 20, 2024)
52-week high$11.4532
52-week low$9.9491
Median price$10.7864
Average price$10.4006
Largest weekly change+40.1% (Apr 20, 2016)
Weeks tracked295
Tracking sinceOct 7, 2015

Price History

1W

0.0%

1M

-2.8%

3M

-2.6%

6M

-3.2%

1Y

+10.3%

3Y

+7.3%

5Y

+7.3%

All

+15.1%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PIOGLITAZONE-GLIMEPIRIDE 30-4?

The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE-GLIMEPIRIDE 30-4, manufactured by Prasco Laboratories, is $10.9734 per EA (NDC 66993082230), effective Jun 24, 2026.

How has the price of PIOGLITAZONE-GLIMEPIRIDE 30-4 changed over time?

Over the history we have for it, the NADAC for PIOGLITAZONE-GLIMEPIRIDE 30-4 has risen 15.1%. It has been tracked across 295 weekly CMS publications since Oct 7, 2015.

What are the highest and lowest recorded NADAC prices for PIOGLITAZONE-GLIMEPIRIDE 30-4?

Since Oct 7, 2015, the NADAC for PIOGLITAZONE-GLIMEPIRIDE 30-4 has ranged from a low of $7.7896 (Nov 20, 2024) to a high of $13.3590 (May 11, 2016), with a median of $10.7864 per EA.

Are there cheaper alternatives to PIOGLITAZONE-GLIMEPIRIDE 30-4?

1 NADAC-published product shares the same active ingredient, strength, and dosage form as PIOGLITAZONE-GLIMEPIRIDE 30-4, but none are currently priced below it.

Who manufactures PIOGLITAZONE-GLIMEPIRIDE 30-4?

PIOGLITAZONE-GLIMEPIRIDE 30-4 (NDC 66993082230) is labeled by Prasco Laboratories, and CMS classifies it as a generic product.